Last reviewed · How we verify

NCT05823220

A Pragmatic Trial Integrating Homelessness Diversion Services Into an Emergency Department Discharge System

ENROLLING BY INVITATION NA Last updated 28 January 2025
What this trial tests

NA trial testing Homeless diversion (HD) in Homelessness in 1,000 participants. Enrolling by invitation.

Timeline
14 September 2023
Primary endpoint
1 September 2025
1 September 2025

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1,000
Start date14 September 2023
Primary completion1 September 2025
Estimated completion1 September 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Homelessness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether a homelessness diversion program integrated into a hospital emergency department (ED) will lower ED use, to identify characteristics of individuals most likely to benefit from homelessness diversion and to discover opportunities to tailor Homelessness Diversion (HD) services to better meet the needs of diverse communities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Homelessness

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05823220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing